The 36th Annual Healthcare
Conference will be held in New
York, December 3-5,
2024
ROCKVILLE, Md., Nov. 21,
2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB, the
"Company"), a U.S.-based global biotech company, exclusively
focused on the development of highly differentiated immunotherapies
for the treatment of cancer, today announced that management will
present at the Piper Sandler 36th Annual Healthcare Conference on
December 4, 2024.
Piper Sandler 36th Annual Healthcare Conference Presentation
Details
|
Presentation
Time
|
Wednesday, December 4
at 4:30 p.m. ET
|
|
Presenters
|
Sean Fu, PhD, MBA,
Chief Executive Officer
Phillip Dennis, MD,
PhD, Chief Medical Officer
|
|
Webcast link
|
Here
|
|
Meetings
|
One-on-one and small
group meetings: December 3 – 4, 2024
|
|
Management
Participants
|
Sean Fu, PhD, MBA,
Chief Executive Officer
Joseph Skelton, Chief
Financial Officer
Phillip Dennis, MD,
PhD, Chief Medical Officer
Tyler Ehler, Senior
Director, Investor Relations
|
The webcast will also be available under "Event Calendar"
on I-Mab's IR website
at https://ir.i-mabbiopharma.com/
For more information, please contact your Piper Sandler
representative.
About I-Mab
I-Mab (NASDAQ: IMAB) is a US-based, global biotech company,
exclusively focused on the development of highly differentiated
immunotherapies for the treatment of cancer. I-Mab has established
operations in Rockville, Maryland,
and Short Hills, New Jersey. For
more information, please visit https://www.i-mabbiopharma.com and
follow us on LinkedIn and X.
For more information, please contact:
Tyler Ehler
Senior Director, Investor Relations
IR@imabbio.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/i-mab-to-participate-at-the-piper-sandler-healthcare-conference-302312202.html
SOURCE I-Mab Biopharma
